Auteurs
Checkpoint
Ncbi
Racine
Checkpoint
Ncbi
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Checkpoint (Ncbi)

Index « Auteurs » - entrée « Taio Naniwa »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Taimur Mansoor < Taio Naniwa < Taisheng Li  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 6.
Ident.Authors (with country if any)Title
000287 (2013) Taio Naniwa [Japon] ; Rei Ito ; Maiko Watanabe ; Yoshihito Hayami ; Shinji Maeda ; Kaneshige Sasaki ; Shiho IwagaitsuCase report: successful use of short-term add-on tocilizumab for multirefractory systemic flare of adult-onset Still's disease.
000A13 (2013) Taio Naniwa [Japon] ; Shinya Tamechika [Japon] ; Shiho Iwagaitsu [Japon] ; Shinji Maeda [Japon] ; Hiroyuki Togawa [Japon]Successful Use of Higher-Dose Etanercept for Multirefractory Systemic Flare of Adult-Onset Still's Disease with Liver Failure with No Response to Tocilizumab Therapy.
000C63 (2017) Atsuko Iwai [Japon] ; Taio Naniwa [Japon] ; Shinya Tamechika [Japon] ; Shinji Maeda [Japon]Short-term add-on tocilizumab and intravenous cyclophosphamide exhibited a remission-inducing effect in a patient with systemic lupus erythematosus with refractory multiorgan involvements including massive pericarditis and glomerulonephritis.
001647 (2017) Shiho Iwagaitsu [Japon] ; Taio Naniwa [Japon]Improvement of Arterial Wall Lesions in Parallel with Decrease of Plasma Pentraxin-3 Levels in a Patient with Refractory Takayasu Arteritis after Treatment with Tocilizumab.
002581 (2019) Shinji Maeda [Japon] ; Satoshi Osaga [Japon] ; Tomoyo Maeda [Japon] ; Norihisa Takeda [Japon] ; Shin-Ya Tamechika [Japon] ; Taio Naniwa [Japon] ; Akio Niimi [Japon]Circulating Th17.1 cells as candidate for the prediction of therapeutic response to abatacept in patients with rheumatoid arthritis: An exploratory research
002B13 (2020) Takahiko Sugihara [Japon] ; Hitoshi Hasegawa ; Haruhito A. Uchida [Japon] ; Hajime Yoshifuji [Japon] ; Yoshiko Watanabe [Japon] ; Eisuke Amiya [Japon] ; Yasuhiro Maejima [Japon] ; Masanori Konishi [Japon] ; Yohko Murakawa [Japon] ; Noriyoshi Ogawa [Japon] ; Shunsuke Furuta [Japon] ; Yasuhiro Katsumata [Japon] ; Yoshinori Komagata [Japon] ; Taio Naniwa [Japon] ; Takahiro Okazaki [Japon] ; Yoshiya Tanaka [Japon] ; Tsutomu Takeuchi [Japon] ; Yoshikazu Nakaoka [Japon] ; Yoshihiro Arimura [Japon] ; Masayoshi Harigai [Japon] ; Mitsuaki Isobe [Japon]Associated factors of poor treatment outcomes in patients with giant cell arteritis: clinical implication of large vessel lesions

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Ncbi/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i -k "Taio Naniwa" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/Author.i  \
                -Sk "Taio Naniwa" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    Taio Naniwa
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021